Literature DB >> 11046069

Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c.

P A Sieling1, S A Porcelli, B T Duong, F Spada, B R Bloom, B Diamond, B H Hahn.   

Abstract

To understand the mechanism of T cell help for IgG production in systemic lupus erythematosus (SLE) we investigated the response of CD4- and CD8-negative (double-negative (DN)) T cells because 1) DN T cells are present at unusually high frequency in patients with SLE and can induce pathogenic autoantibodies; 2) the DN T cell repertoire includes cells restricted by CD1 Ag-presenting molecules; and 3) CD1c is expressed on a population of circulating B cells. We derived DN T cell lines from SLE patients and healthy individuals. In the presence of CD1(+) APCs, DN T cell lines from SLE patients produced both IL-4 and IFN-gamma, whereas DN T cells from healthy donors produced IFN-gamma, but no IL-4. In general, cells from patients with highly active disease produced high levels of IFN-gamma; cells from those with little activity produced high IL-4. Coculture of CD1c-directly reactive T cells from healthy donors with CD1c(+) B cells elicited IgM Abs, but little or no IgG. In contrast, CD1c-directly reactive T cells from SLE patients induced isotype switching, with a striking increase in IgG production. Neutralizing Abs to CD1c inhibited the ability of DN T cells to induce IgG production from CD1c(+) B cells, further indicating that CD1c mediated the T and B cell interaction. IgG production was also inhibited by neutralizing Abs to IL-4, correlating with the cytokine pattern of DN T cells derived from these patients. The data suggest that CD1c-restricted T cells from SLE patients can provide help to CD1c(+) B cells for IgG production and could therefore promote pathogenic autoantibody responses in SLE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046069     DOI: 10.4049/jimmunol.165.9.5338

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

Review 3.  Lipids hide or step aside for CD1-autoreactive T cell receptors.

Authors:  Rachel N Cotton; Adam Shahine; Jamie Rossjohn; D Branch Moody
Journal:  Curr Opin Immunol       Date:  2018-05-05       Impact factor: 7.486

4.  Villous B cells of the small intestine are specialized for invariant NK T cell dependence.

Authors:  Peter Velázquez; Bo Wei; Michael McPherson; Lesley Marie A Mendoza; Sandra L Nguyen; Olga Turovskaya; Mitchell Kronenberg; Tiffany T Huang; Matthew Schrage; Lynn N Lobato; Daisuke Fujiwara; Sarah Brewer; Moshe Arditi; Genhong Cheng; R Balfour Sartor; Rodney D Newberry; Jonathan Braun
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 5.  mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.

Authors:  Andras Perl
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

6.  Elevated double negative T cells in pediatric autoimmunity.

Authors:  James A Tarbox; Molly P Keppel; Nermina Topcagic; Charles Mackin; Miriam Ben Abdallah; Kevin W Baszis; Andrew J White; Anthony R French; Megan A Cooper
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

7.  A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2.

Authors:  Di Wu; Hongwu Wang; Weiming Yan; Tao Chen; Ming Wang; Meifang Han; Zeguang Wu; Xiaojing Wang; Guo Ai; Dong Xi; Guanxin Shen; Xiaoping Luo; Qin Ning
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

8.  A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1+ TCRs.

Authors:  Tingxi Guo; Ming Yin Koo; Yuki Kagoya; Mark Anczurowski; Chung-Hsi Wang; Kayoko Saso; Marcus O Butler; Naoto Hirano
Journal:  J Immunol       Date:  2017-12-13       Impact factor: 5.422

Review 9.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

10.  CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs.

Authors:  Annemieke de Jong; Eva Casas Arce; Tan-Yun Cheng; Ruben P van Summeren; Ben L Feringa; Vadim Dudkin; David Crich; Isamu Matsunaga; Adriaan J Minnaard; D Branch Moody
Journal:  Chem Biol       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.